100,000 doses of Janssen’s COVID-19 delivered to Ukraine under COVAX initiative

A total of 100,000 doses of Janssen’s COVID-19 vaccine – Ad26.COV2-S – have been delivered to Ukraine this month under the COVAX initiative, and distributed to 22 regions in the country by the Ministry of Health, the World Health Organization (WHO) announced. Additionally, more than 100 medical workers and trainers across Ukraine have been taught by WHO to conduct further training on the use of Ad26.COV2-S, and Ukrainian healthcare workers have received over 23,000 copies of guidance materials on the use of the vaccine. Ad26.COV2-S – also known as JNJ-78436735 or Jcovden – was approved for emergency use by WHO and registered in Ukraine in July 2021 for the vaccination of adults aged 18-years-old and over.